Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRRA | FDMT | IRWD | ||
| Company | Sierra Oncology Inc | 4D Molecular Therapeutics Inc | Ironwood Pharmaceuti | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.98 | 25.31 | 8.25 | ||
| High | 55.17 | 26.54 | 8.32 | ||
| Low | 54.98 | 24.93 | 8.11 | ||
| Last | 54.99 | 26.38 | 8.30 | ||
| Change | +0.02 | +0.99 | +0.08 | ||
| % Change | +0.04% | +3.90% | +0.97% | ||
| Volume | 862,800 | 456,800 | 1,598,200 | ||
| 20-Day Average Volume | 396,690 | 482,050 | 2,527,975 | ||
| Previous Close | 54.97 | 25.39 | 8.22 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.91 | 25.80 | 7.97 | ||
| 20-Day Raw Stochastic | 62.96% | 55.72% | 85.56% | ||
| 20-Day Relative Strength | 77.35% | 49.23% | 44.21% | ||
| Weighted Alpha | +89.10 | +17.78 | +2.28 | ||
| Today's Opinion | 100% Buy | 56% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 40% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 06/23/22 | +12.11% since 04/25/24 | +2.72% since 04/25/24 | ||
| Low | 54.65 on 06/24/22 | 22.75 on 04/26/24 | 7.69 on 04/29/24 | ||
| High | 55.19 on 06/24/22 | 26.59 on 05/01/24 | 8.43 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | +0.38% since 05/27/22 | -5.72% since 04/02/24 | +0.97% since 04/02/24 | ||
| Low | 54.58 on 05/31/22 | 22.75 on 04/26/24 | 7.53 on 04/18/24 | ||
| High | 55.19 on 06/24/22 | 29.26 on 04/08/24 | 8.43 on 05/01/24 | ||
| 3-Month | |||||
| %Chg | +69.83% since 03/30/22 | +50.83% since 02/02/24 | -43.11% since 02/02/24 | ||
| Low | 30.87 on 03/31/22 | 22.75 on 04/26/24 | 7.53 on 04/18/24 | ||
| High | 55.19 on 06/24/22 | 36.25 on 03/27/24 | 15.70 on 02/14/24 | ||
| 6-Month | |||||
| %Chg | +144.40% since 12/30/21 | +144.94% since 11/02/23 | -7.68% since 11/02/23 | ||
| Low | 14.91 on 01/24/22 | 9.73 on 11/10/23 | 7.53 on 04/18/24 | ||
| High | 55.19 on 06/24/22 | 36.25 on 03/27/24 | 15.70 on 02/14/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,342,801 | 1,349,522 | 1,299,191 | ||
| Shares Outstanding, K | 24,419 | 51,157 | 156,529 | ||
| Annual Sales | 0 | 20,720,000 | 442,740,000 | ||
| Annual Net Income | -94,660,000 | -100,840,000 | -1,002,240,000 | ||
| Last Quarter Sales | 0 | 20,200,000 | 117,550,000 | ||
| Last Quarter Net Income | -27,930,000 | -10,260,000 | -1,090,000 | ||
| 60-Month Beta | 0.01 | 2.94 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.33 on 05/06/22 | -0.77 on 02/29/24 | 0.00 on 02/15/24 | ||
| Latest Earnings Date | 08/04/22 | 05/08/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 12.09 | ||